ELISA kit for detecting human serum dlk1 protein and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI JIAOTONG UNIV
- Publication Date
- 2020-08-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biological detection, in particular to an ELISA kit for detecting human serum DLK1 protein and its application. Background technique
[0002] Hepatocellular carcinoma (HCC) has a high incidence in my country and is the fifth most common malignant tumor in the world. It lacks early preventive diagnosis and treatment measures, high degree of malignancy, rapid progression, poor prognosis, little curative effect of chemotherapy, surgery Treatment is difficult to cure. In my country, the morbidity and mortality of liver cancer ranks second among cancers. The occurrence of liver cancer is a multi-stage, multi-factor cumulative effect, as well as the result of the involvement and mutation of multiple genes, and its specific etiology and pathogenesis have not yet been clarified. The known possible external causes of primary liver cancer include viral hepatitis, liver cirrhosis, aflatoxin, drinking water pollution...